Corrigendum: Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells

Front Immunol. 2024 Feb 8:15:1379325. doi: 10.3389/fimmu.2024.1379325. eCollection 2024.

Authors

Zhenyu Wei¹, Jiayu Xu¹, Chengkui Zhao^{1

2}, Min Zhang¹, Nan Xu^{2

3}, Liqing Kang^{2

3}, Xiaoyan Lou^{2

3}, Lei Yu^{2

3}, Weixing Feng¹

Affiliations

¹ Intelligent Systems Science and Engineering College, Harbin Engineering University, Harbin, China.
² Shanghai Unicar-Therapy BioMedicine Technology Co., Ltd, Shanghai, China.
³ School of Chemical and Molecular Engineering, East China Normal University, Shanghai, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1273507.].

Keywords: CAR-T cell therapy; biomarker; cytokine release syndrome (CRS); decision tree; prediction.

Copyright © 2024 Wei, Xu, Zhao, Zhang, Xu, Kang, Lou, Yu and Feng.

Publication types

Published Erratum